Cyclin kinase inhibitor p21(WAF1/CIP1) in malignant melanoma: Reduced expression in metastatic lesions

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 1813-1822

  Mælandsmo, Gunhild Mari ^a   Holm, Ruth ^a   Fodstad, Øystein ^a   Kerbel, Robert S ^b,c   Flørenes, Vivi Ann ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PROTEIN P21; RNA;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PHENOTYPE; PRIORITY JOURNAL;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029805005     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Hunter T, Pines J: Cyclins and cancer, II. Cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582
2. Kamb A: Cell-cycle regulators and cancer. Trends Genet 1995, 11:136-140
3. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992, 71:505-514
4. Zhang H, Xiong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 1993, 4:897-906
5. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704
6. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816
7. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interacting with PCNA. Nature 1994, 369: 574-578
8. Li R, Waga S, Hannon GJ, Beach D, Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994, 371: 534-537
9. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995, 6:387-400
10. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994, 8:1750-1758
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
12. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang W-W, Wade Harper J, Thompson TC: In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 1995, 55:5151-5155
13. WAF1. Cancer Res 1995, 55:4536-4539
14. Di Leonardo A, Linke SP, Clarkin K, Wahl GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 1994, 8:2540-2551
15. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90-98
16. Steinman RA, Hoffman B, Ira A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 1994, 9:3389-3396
17. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994, 9:3397-3406
18. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 1995, 11:493-504
19. Albino AP, Fountain JW: Molecular genetics of human malignant melanoma. Cancer Treat Res 1993, 65:201-255
20. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB: Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990, 247: 568-571
21. Vidai MJ, Loganzo F Jr, de Oliveira AR, Hayward NK, Albino AP: Mutations and defective expression of the WAF1 p21 tumor-suppressor gene in malignant melanomas. Melanoma Res 1995, 5:243-250
22. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB: The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 1995, 10:1855-1864
23. Flørenes VA, Øyjord T, Holm R, Skrede M, Børresen A-L, Nesland JM, Fodstad Ø: TP53 allele loss, mutations and expression in malignant melanoma. Br J Cancer 1994, 69:253-259
24. Flørenes VA, Holm R, Fodstad Ø: Accumulation of p53 protein in human malignant melanoma: relationship to clinical outcome. Melanoma Res 1995, 5:183-187
25. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, Koprowski H: Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985, 45:5670-5676
26. Herlyn M: Human melanoma: development and progression. Cancer Metastasis Rev 1990, 9:101-112
27. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981, 75:734-738
28. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992, 168: 357-363
29. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
30. Mælandsmo GM, Flørenes VA, Hovig E, Øyjord T, Engebråten O, Holm R, Børresen A-L, Fodstad Ø: Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer 1996, 73:909-916
31. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 1984, 81:1991-1995
32. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995, 55:2910-2919
33. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by ap53-independent pathway. Cancer Res 1994, 54:3391-3395
34. WAF1/CIP1 in human brain tumors. Oncogene 1995, 11:2021-2028
35. WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int J Cancer 1995, 63:611-615
36. Ponten F, Berne B, Ren ZP, Nister M, Ponten J: Ultraviolet light induces expression of p53 and p27 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 1995, 105:402-406
37. Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR: Transforming growth factor-β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 1994, 5:1301-1307
38. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995, 92: 5545-5549
39. KIP1. Oncogene 1996 (in press)
40. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 1995, 55: 668-674
41. Reed JA, Loganzo F Jr, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW, Albino AP: Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995, 55:2713-2718
42. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264: 436-440
43. Xiao S, Li D, Corson JM, Vijg J, Fletcher JA: Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 1995, 55:2968-2971
44. Nasmyth K, Hunt T: Cell cycle: dams and sluices. Nature 1993, 366:634-635
45. Pines J: Arresting developments in cell-cycle control. Trends Biol Sci 1994, 4:143-145